
|Videos|October 11, 2016
Weighing Quality of Life Improvements in Atopic Dermatitis
Advertisement
Episodes in this series

Panelists Peter L. Salgo, MD; Ed Pezalla, MD, MPH; Jeffrey D. Dunn, PharmD, MBA; and Cheryl Allen, BS Pharm, MBA, highlight the triggers to seek clinical care and the direct and indirect costs associated with the disease.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Early Recognition and Routine Discussion: Improving Outcomes in Tardive Dyskinesia
2
Targeting CSF1R in TGCT: Evaluating the Evidence and Empowering Pharmacist-Led Care
3
Meet the FDA’s Newly Approved OTC Sunscreen Ingredient: Bemotrizinol
4
Do GLP-1 Receptor Agonists Increase the Risk of Smell and Taste Disturbances?
5






























































































































